Table 1 Clinical characteristics of examined women with ovarian cancer (n = 149)
From: Antibodies against Hsp60 and Hsp65 in the sera of women with ovarian cancer
Clinical data | Number of patients (%) |
|---|---|
Antineoplastic treatment: | |
  • Untreated so far | 72 (48,3) |
  • After chemotherapy | 77 (51,7) |
Histopathological type of ovarian cancer: | |
  • Adenocarcinoma papillare serosum | 82 (55,0) |
  • Adenocarcinoma mucinosum | 44 (29,6) |
  • Adenocarcinoma endometrioides | 23 (15,4) |
Stage of the clinical progresion (by FIGO): | |
  • I | 25 (16,8) |
  • II | 31 (20,8) |
  • III | 60 (40,3) |
  • IV | 33 (22,1) |